BMC Medical Co. Ltd. A (SHE:301367) — Stock Price
BMC Medical Co. Ltd. A (SHE:301367) is currently trading at CN¥46.34 CNY, up 0.15% today. Over the past 52 weeks, shares have ranged between CN¥38.58 and CN¥97.99. This page tracks BMC Medical Co. Ltd. A's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 301367 market cap overview.
BMC Medical Co. Ltd. A (301367) Stock Price Chart — Daily History & Trading Volume
The chart below tracks BMC Medical Co. Ltd. A's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
BMC Medical Co. Ltd. A Income Statement — Revenue, Profit & Earnings by Year
BMC Medical Co. Ltd. A's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥1.16 Billion | CN¥843.48 Million | CN¥1.12 Billion | CN¥1.42 Billion | CN¥662.50 Million |
| Cost of Revenue | CN¥545.71 Million | CN¥435.72 Million | CN¥606.75 Million | CN¥826.09 Million | CN¥376.00 Million |
| Gross Profit | CN¥613.70 Million | CN¥407.76 Million | CN¥515.67 Million | CN¥589.28 Million | CN¥286.50 Million |
| Research & Development | CN¥139.12 Million | CN¥124.62 Million | CN¥116.98 Million | CN¥72.86 Million | CN¥48.28 Million |
| SG&A | CN¥156.81 Million | CN¥91.29 Million | CN¥77.46 Million | CN¥62.05 Million | CN¥44.48 Million |
| Total Operating Expenses | CN¥917.76 Million | CN¥721.45 Million | CN¥833.86 Million | CN¥1.01 Billion | CN¥505.64 Million |
| Operating Income | CN¥241.65 Million | CN¥122.03 Million | CN¥288.56 Million | CN¥408.20 Million | CN¥156.86 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | CN¥4.97 Million | CN¥2.85 Million | CN¥1.36 Million | CN¥463.67K | CN¥196.62K |
| Income Before Tax | CN¥261.36 Million | CN¥176.14 Million | CN¥334.03 Million | CN¥435.09 Million | CN¥163.86 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | CN¥225.66 Million | CN¥155.38 Million | CN¥297.34 Million | CN¥380.30 Million | CN¥145.68 Million |
BMC Medical Co. Ltd. A Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes BMC Medical Co. Ltd. A's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥3.38 Billion | CN¥3.42 Billion | CN¥2.92 Billion | CN¥2.93 Billion | CN¥623.69 Million |
| Total Current Assets | CN¥3.06 Billion | CN¥3.14 Billion | CN¥2.79 Billion | CN¥2.85 Billion | CN¥589.46 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥1.52 Billion | CN¥2.29 Billion | CN¥1.81 Billion | CN¥2.16 Billion | CN¥295.00 Million |
| Net Receivables | CN¥241.77 Million | CN¥186.46 Million | CN¥108.58 Million | CN¥92.64 Million | CN¥24.43 Million |
| Inventory | CN¥115.79 Million | CN¥102.41 Million | CN¥118.01 Million | CN¥203.31 Million | CN¥117.22 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | CN¥0.00 |
| Total Liabilities | CN¥341.39 Million | CN¥587.28 Million | CN¥131.62 Million | CN¥309.66 Million | CN¥132.41 Million |
| Total Current Liabilities | CN¥338.24 Million | CN¥578.63 Million | CN¥112.25 Million | CN¥289.38 Million | CN¥128.48 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | CN¥3.03 Billion | CN¥2.83 Billion | CN¥2.78 Billion | CN¥2.61 Billion | CN¥491.28 Million |
| Retained Earnings | CN¥1.18 Billion | CN¥996.45 Million | CN¥910.47 Million | CN¥741.13 Million | CN¥366.28 Million |
BMC Medical Co. Ltd. A Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how BMC Medical Co. Ltd. A generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥130.16 Million | CN¥154.08 Million | CN¥151.11 Million | CN¥375.21 Million | CN¥104.40 Million |
| Capital Expenditures | CN¥32.22 Million | CN¥15.93 Million | CN¥24.12 Million | CN¥23.75 Million | CN¥10.03 Million |
| Free Cash Flow | CN¥97.94 Million | CN¥138.16 Million | CN¥126.98 Million | CN¥351.46 Million | CN¥94.38 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | CN¥41.94 Million | CN¥65.79 Million | CN¥128.00 Million | — | CN¥28.80 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥22.29 Million | CN¥21.93 Million | CN¥19.40 Million | CN¥8.74 Million | CN¥8.81 Million |
| Change in Cash | CN¥603.60 Million | CN¥-202.73 Million | CN¥312.84 Million | CN¥241.89 Million | CN¥-104.32 Million |
BMC Medical Co. Ltd. A Earnings History — EPS Actual vs. Analyst Estimates
Track BMC Medical Co. Ltd. A's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 28, 2026 | 0.71 | — | — |
| Apr 28, 2026 | 0.31 | — | — |
| Dec 31, 2025 | 0.37 | — | — |
| Sep 30, 2025 | 0.39 | — | — |
| Jun 30, 2025 | 0.48 | — | — |
| Apr 24, 2025 | 0.81 | — | — |
| Dec 31, 2024 | 0.24 | — | — |
| Oct 24, 2024 | 0.37 | — | — |